US2004157265A1PendingUtilityA1
Method for detecting rheumatoid arthritis employing the CB10 peptide of mammalian type II collagen as an antigen
Assignee: MONTECH MEDICAL DEVELOPMENTS PPriority: Mar 19, 1997Filed: Feb 9, 2004Published: Aug 12, 2004
Est. expiryMar 19, 2017(expired)· nominal 20-yr term from priority
Y10S436/807Y10S436/804G01N 33/564G01N 2333/78Y10S436/80
26
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An highly specific and sensitive approach to detecting antibodies to collagen in a biological sample entails contacting the sample with an antigen that comprises the CB10 peptide of mammalian type II collagen, or with an antibody-binding fragment of that peptide, under conditions conducive to formation of an antibody-antigen complex, which then is detected.
Claims
exact text as granted — not AI-modified1 . A kit detecting anti-collagen antibody in a biological sample, wherein said antibody is associated with rheumatoid arthritis, comprising (i) an antigenic preparation comprising the CB10 peptide of mammalian type II collagen or an antibody-binding fragment of said peptide and (ii) means for detecting a complex formed between said antigenic preparation and antibody from said sample.
2 . A diagnostic kit for the detection of antibodies to collagen in a biological sample from a patient, comprising, in compartmental form, an antigenic preparation comprising the CB10 peptide of mammalian type II collagen, or an antibody-binding fragment or variant thereof, and means for detection of a complex formed between said antigen and antibodies to collagen in said biological sample.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.